Anthony R Martin
10PUBLICATIONS
37CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Apr 01, 2026
Dual targeting of GPX4 and TXNRD1 triggers eradication of AML cells through induction of apoptosis and ferroptosis.Cécile Favreau, Maxence Bourgoin, Coline Savy
|Jan 22, 2026
Molecular engineering of lysosome-based degraders unveils a rapidly expanding therapeutic strategy.Adele Rivault, Jade Dussart-Gautheret, Rachid Benhida
|Jan 14, 2026
EGFR inhibitor-resistant lung cancers exhibit collateral sensitivity to a covalent, cysteine-independent KEAP1 oligomerizing molecular bridge.Christopher F Bassil, Kerry Dillon, Gray R Anderson
|Aug 30, 2025
Targeting pregnane X receptor with a potent agonist-based PROTAC to delay colon cancer relapse.Lucile Bansard, Guillaume Laconde, Vanessa Delfosse
|May 30, 2024
Targeting a lineage-specific PI3Kɣ-Akt signaling module in acute myeloid leukemia using a heterobifunctional degrader molecule.Lois M Kelly, Justine C Rutter, Kevin H Lin
|Jun 17, 2023
Covalent-reversible peptide-based protease inhibitors. Design, synthesis, and clinical success stories.Anthony Feral, Anthony R Martin, Alexandre Desfoux
Pageof 2
Frequent Collaborators
2 joint publications
Guillaume Robert
2 joint publications
Alexandre Puissant
2 joint publications
Shane T Killarney
2 joint publications
Kris C Wood
1 joint publications
Arnaud Jacquel
1 joint publications
Mohsine Driowya
1 joint publications
Frédéric Luciano
1 joint publications
Stéphane Rocchi
1 joint publications
Anthony Feral
1 joint publications
Alexandre Desfoux
